StonvexLoading…
StonvexStonvexStonvexCore line items from ADTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.19K | $133.99K | $645.18K | $933.72K |
Operating Income | $-19.57M | $-27.86M | $-26.06M | $-25.48M |
Net Income | $-43.10M | $-40.35M | $-32.70M | $-27.65M |
EPS (Diluted) | $-1153.83 | $-22147415.22 | $-27038.26 | $-595.60 |
Total Assets | $16.52M | $32.14M | $44.58M | $10.74M |
Total Liabilities | $12.56M | $23.86M | $28.53M | $5.53M |
Cash & Equivalents | $3.20M | $833.03K | $97.10K | $2.77M |
Free Cash Flow OCF − CapEx | $-25.70M | Not available | $-19.22M | $-22.76M |
Shares Outstanding | 411.50K | 193 | 165 | 107.65K |